Barclays Maintains an 'Equalweight' on Sara Lee (SLE); Is SLE's Value Bigger than a Breadbox?

November 9, 2010 1:17 PM EST Send to a Friend
Barclays maintains an 'Equalweight' on Sara Lee (NYSE: SLE), price target $14.

Barclays analyst says, "When we first met CFO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login